Atlas Trials

Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria

Clinical trial NCT02579044 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT02579044
Sponsor
Boston Children's Hospital
Status
ENROLLING_BY_INVITATION
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Progeria
Start date
2015-12-01
Primary completion
2027-03-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.